THE WOODLANDS, Texas--(BUSINESS WIRE)--Opexa Therapeutics, Inc. (NASDAQ:OPXA), a company developing Tcelna™, a novel T-cell therapy for multiple sclerosis (MS), today announced that Neil Warma, President and Chief Executive Officer, will participate in two upcoming industry conferences. Details regarding these events are as follows:
“Personalized Medicine From a Drug Developer’s Point of View”
Intellectual Property Owners Association (IPO) Annual Meeting
This conference will take place September 9-11, 2012 at the JW Marriott Hill Country in San Antonio, Texas.
